Compare IFBD & SSKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IFBD | SSKN |
|---|---|---|
| Founded | 2001 | 1989 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.4M | 8.9M |
| IPO Year | 2021 | 2005 |
| Metric | IFBD | SSKN |
|---|---|---|
| Price | $0.99 | $1.28 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 19.1K | ★ 118.0K |
| Earning Date | 05-01-2023 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $4,861,442.00 | ★ $30,980,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $7.74 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 1520.48 | N/A |
| 52 Week Low | $0.88 | $1.18 |
| 52 Week High | $2.70 | $3.86 |
| Indicator | IFBD | SSKN |
|---|---|---|
| Relative Strength Index (RSI) | 46.54 | 43.35 |
| Support Level | $0.93 | $1.18 |
| Resistance Level | $1.15 | $1.45 |
| Average True Range (ATR) | 0.08 | 0.10 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 20.25 | 24.62 |
Infobird Co Ltd is engaged in developing and providing customer engagement cloud-based services. It software-as-a-service provider of AI-powered, or artificial intelligence-enabled, customer engagement solutions in China. It provides holistic software solutions to help corporate clients proactively deliver and manage end-to-end customer engagement activities at all stages of the sales process, including pre-sales and sales activities, and post-sales customer support. It also offers AI-powered cloud-based sales force management software, including intelligent quality inspection and intelligent training software to help clients monitor, benchmark, and improve the performance of agents.
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.